Institutional Review Board (IRB) for Clinical Research

Mission Statement

Ingham Regional Medical Center (IRMC) is a community-based, university-affiliated teaching hospital, whose primary mission is to improve the health and well-being of the people of the mid-Michigan community. Its Institutional Review Board for Clinical Research (IRB) was established to advance the goal of conducting research with diligence and integrity. It is an appropriately constituted group that has been formally designated to review and monitor research involving human subjects. The purpose of the IRB is to ensure protection of the rights, welfare and privacy of human subjects who participate in research conducted entirely or in part at IRMC. To achieve this goal, the IRB will 1) require all investigators be educated in the use of human subjects, 2) review all proposed research involving human subjects prior to initiation of the research, 3) approve, modify or disapprove research according to established criteria for protection of human subjects, and 4) monitor approved research to ascertain that human subjects are indeed protected during the performance of the research. The processes of education, review and monitoring serve to ensure the safe and ethical conduct of research that will protect human subjects in an atmosphere of mutual trust and integrity in the pursuit of knowledge and human benefit. The investigators and members of the IRB will be guided by the ethical principles outlined in the Belmont Report and the federal requirements (45 CFR 46, 21 CFR 50, 21 CFR 56).

All research conducted within the Ingham Regional Medical Center system involving human subjects or human materials must have prior approval by the IRB. This includes, but is not limited to, investigations conducted by IRMC medical/clinical staff, and faculty and/or students at MSU* or other institutions, and others interested in research. The type of IRB review required (exempt, expedited, or full board), depends upon the classification of the research proposal and on the levels of risk to subjects.

• Faculty and/or students at MSU wishing to conduct research at an IRMC facility must obtain MSU approval as well as IRMC IRB approval. (See "IRMC Initial Review of CRIRB-Approved Project" or "Reliance Review" policies)

IRB Contact Information

Investigators are encouraged to contact the IRB office with any questions, concerns or suggestions regarding the human research protection program, including the IRB review process, the IRMC/MSU IRB Reliance Agreement, or the CRIRB Collaborative Agreement.

If you have any concerns or complaints about a specific research study done at Ingham Regional Medical Center facilities, please contact the IRB Chair, Dr. David DeBiose, or the Research Systems Administrator.

IRB Chair:  David DeBiose, D.O.
Research Systems Administrator:  Mary F. O’Connor, RN, BSN
Email:  IRMC-IRB@irmc.org
Pager: 517.794.4945
Phone: 517.975.1105
Fax: 517.975.1110

Website: www.irmc.org/irb

Availability
Monday - Friday 8:00am – 5:00pm (Except all hospital holidays)